Sign inJoin waitlistJoin the waitlist

Vaishali Sanchorawala

Director of Stem Cell Transplantation Program · Boston Medical Center

Credentials: · · ·

History

Stem Cell Transplantation Program · Boston Medical Center
Present
Amyloidosis Center · Chobanian and Avedisian School of Medicine
Present
Boston University Chobanian & Avedisian School of Medicine
Present

Seth G.S. Medical College

Research

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and…
Review · American Journal of Hematology · 2005 · 1,170 citations
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
New England Journal of Medicine · 2021 · 562 citations
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution…
Journal of the American College of Cardiology · 2023 · 520 citations

DS
David Seldin
73 papers
Mark Sloan
53 papers
Karen Quillen
44 papers · 2 as a fellow
John Berk
42 papers
MS
Martha Skinner
42 papers
Andrew Staron
32 papers · 14 as a fellow
Frederick Ruberg
32 papers
Shayna Sarosiek
30 papers · 2 as a fellow
RC
Raymond Comenzo
28 papers
Angela Dispenzieri
24 papers
HL
Heather Landau
23 papers
Lisa Mendelson
23 papers

Clinical trials

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis
Principal investigator · Unknown · Phase 1, Phase 2
Sorrento Therapeutics, Inc.
2021–2024
Daratumumab for the Treatment of Patients With AL Amyloidosis
Principal investigator · Completed · Phase 1, Phase 2
Boston Medical Center
2017–2020
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
Principal investigator · Terminated · Phase 3
Boston Medical Center
2015–2017
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
Principal investigator · Completed · Phase 1, Phase 2
Boston Medical Center
2012–2019